Avid Bioservices, Inc. (CDMO): Price and Financial Metrics
CDMO Price/Volume Stats
| Current price | $7.35 | 52-week high | $18.86 |
| Prev. close | $7.32 | 52-week low | $4.07 |
| Day low | $7.29 | Volume | 1,268,400 |
| Day high | $7.68 | Avg. volume | 1,270,254 |
| 50-day MA | $7.03 | Dividend yield | N/A |
| 200-day MA | $8.11 | Market Cap | 466.58M |
CDMO Stock Price Chart Interactive Chart >
Avid Bioservices, Inc. (CDMO) Company Bio
Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate includes bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company was founded in 1981 and is based in Tustin, California.
Latest CDMO News From Around the Web
Below are the latest news stories about AVID BIOSERVICES INC that investors may wish to consider to help them evaluate CDMO as an investment opportunity.
Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices IncInvestors often keep a close eye on insider transactions as they can provide valuable insights into a company's prospects. |
Avid Bioservices, Inc. (CDMO) Q2 2024 Earnings Call TranscriptAvid Bioservices, Inc. (CDMO) Q2 2024 Earnings Conference Call December 7, 2023, 4:30 PM ET Company Participants Tim Brons - Investors Relations Group Nick Green - President and CEO Dan Hart - Chief Financial Officer Matt Kwietniak - Chief Commercial Officer Conference Call Participants Jacob Johnson - Stephens Matt Hewitt - Craig-Hallum Paul Knight - KeyBanc Max Smock - William Blair Thomas Kelliher - RBC Capital Markets Presentation Operator Good day, ladies and gentlemen. And welcome to the Avid Bioservices Second Quarter Fiscal 2024 Financial Results Conference Call. At this time, all participants are in a listen-only ... |
JOBY Stock: Joby Aviation Announces Partnerships to Boost eVTOL InfrastructureJoby Aviation stock is climbing higher on Friday as investors in the company react to a new partnership to bring eVTOLs to Japan. |
Morgan Stanley Is Pounding the Table on First Solar (FSLR) StockFirst Solar stock is climbing higher on Friday after shares of FSLR were given an upgrade and increased price target from Morgan Stanley. |
Why Is Avid Bioservices (CDMO) Stock Down 18% Today?Avid Bioservices stock is falling hard on Friday as investors in CDMO react to a lackluster earnings report and a guidance cut. |
CDMO Price Returns
| 1-mo | 9.70% |
| 3-mo | 8.57% |
| 6-mo | 19.90% |
| 1-year | -59.28% |
| 3-year | -66.33% |
| 5-year | 54.41% |
| YTD | 13.08% |
| 2023 | -52.80% |
| 2022 | -52.81% |
| 2021 | 152.86% |
| 2020 | 50.46% |
| 2019 | 87.07% |
Continue Researching CDMO
Want to do more research on Avid Bioservices Inc's stock and its price? Try the links below:Avid Bioservices Inc (CDMO) Stock Price | Nasdaq
Avid Bioservices Inc (CDMO) Stock Quote, History and News - Yahoo Finance
Avid Bioservices Inc (CDMO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...